Two Sigma Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-15,000
Closed -$929K 2631
2014
Q3
$929K Buy
15,000
+2,000
+15% +$127K 0.01% 1168
2014
Q2
$829K Sell
13,000
-122,000
-90% -$7.41M 0.01% 1306
2014
Q1
$8.31M Buy
135,000
+49,200
+57% +$2.87M 0.08% 287
2013
Q4
$4.92M Buy
85,800
+40,800
+91% +$2.31M 0.05% 392
2013
Q3
$2.4M Buy
45,000
+35,000
+350% +$1.88M 0.03% 555
2013
Q2
$515K Buy
+10,000
New +$494K 0.01% 1309

Other funds holding MDT

Two Sigma Advisers's MDT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Medtronic (MDT) in Q1 2026, closing a stake of 51,419 shares — an estimated $4.94M sold.

Two Sigma Advisers first reported a position in MDT in Q2 2013 and held it in 45 quarters. The position peaked at $432M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 51,419 Medtronic shares in Q1 2026, an estimated $4.94M.
  • Two Sigma Advisers first reported a position in Medtronic in Q2 2013 and held it in 45 quarters.
  • Two Sigma Advisers's Medtronic position peaked at $432M in Q4 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.